What Tests Are Used to Diagnose Mesothelioma?
Mesothelioma diagnosis involves a combination of imaging tests (X-rays, CT scans, PET scans, MRI), fluid analysis (thoracentesis or paracentesis), and tissue biopsies. Pathologists then use immunohistochemistry panels to confirm the diagnosis and determine the specific cell type.
Imaging Tests: The First Line of Investigation
When a physician suspects mesothelioma, imaging tests are typically the first diagnostic tools employed. A chest X-ray is often the initial study, which may reveal pleural effusion (fluid around the lungs), pleural thickening, or a visible mass. While an X-ray can raise suspicion, it lacks the resolution to confirm a mesothelioma diagnosis.
A CT scan provides far more detailed cross-sectional images and is the standard imaging modality for evaluating suspected mesothelioma. CT scans can reveal the location and extent of tumors, the degree of pleural thickening, and whether nearby structures such as the chest wall or diaphragm are involved. Contrast-enhanced CT scans are preferred because the contrast agent helps distinguish tumor tissue from surrounding structures.
PET scans use a radioactive glucose tracer to identify areas of high metabolic activity, which are characteristic of cancer cells. PET-CT combines the metabolic information from PET with the anatomical detail of CT, helping physicians determine whether the cancer has spread to lymph nodes or distant organs. MRI may be used in specific situations, particularly to evaluate potential tumor invasion of the diaphragm or chest wall before surgery.
Fluid Analysis: Thoracentesis and Paracentesis
Many mesothelioma patients develop fluid accumulation — pleural effusion in pleural mesothelioma or ascites in peritoneal mesothelioma. Physicians can extract this fluid through thoracentesis (from the chest cavity) or paracentesis (from the abdominal cavity) and submit it for cytological analysis.
While fluid cytology can identify malignant cells in some cases, it has significant limitations. Studies indicate that fluid analysis alone can confirm mesothelioma in only about 30–50% of cases. The cells in fluid samples often lack the architectural context that pathologists need to distinguish mesothelioma from adenocarcinoma or reactive mesothelial proliferation. For this reason, a tissue biopsy is almost always required for a definitive diagnosis.
Tissue Biopsy Procedures
A tissue biopsy remains the gold standard for confirming mesothelioma. Several techniques are available depending on the tumor's location and the patient's overall condition. Video-assisted thoracoscopic surgery (VATS) is the most common approach for pleural mesothelioma, allowing the surgeon to directly visualize the pleural surface and obtain generous tissue samples.
CT-guided core needle biopsy is a less invasive alternative that uses imaging to guide a needle into the suspicious area. While it avoids the need for general anesthesia in many cases, it yields smaller tissue samples. Open surgical biopsy (thoracotomy or laparotomy) may be necessary when other approaches cannot obtain adequate tissue or when the clinical situation requires direct surgical evaluation.
Laboratory and Blood Tests
Once tissue samples are obtained, pathologists use immunohistochemistry (IHC) panels to confirm the diagnosis. IHC involves applying antibodies that bind to specific proteins on the cell surface, helping to distinguish mesothelioma from other cancers. Common markers include calretinin, WT-1, cytokeratin 5/6, and D2-40 for mesothelioma, while markers like CEA, TTF-1, and MOC-31 help rule out lung adenocarcinoma.
Blood-based biomarker tests are an emerging area of mesothelioma diagnostics. The MESOMARK assay measures soluble mesothelin-related peptides (SMRP) in the blood, while osteopontin and fibulin-3 are other biomarkers under investigation. These tests are not yet reliable enough for standalone diagnosis but may be useful for monitoring treatment response or screening high-risk individuals with known asbestos exposure histories.
The Importance of Specialized Evaluation
Because mesothelioma is a rare and complex cancer, accurate diagnosis requires pathologists and oncologists with specific experience in asbestos-related diseases. Patients who receive care at specialized cancer centers are more likely to receive an accurate diagnosis and appropriate treatment recommendations. If you have been diagnosed with mesothelioma or suspect you may have the disease, seeking a second opinion from a mesothelioma specialist is a reasonable and often recommended step.
- Imaging tests: X-ray, CT scan, PET scan, MRI
- Fluid analysis: Thoracentesis (chest) or paracentesis (abdomen)
- Tissue biopsy: VATS, thoracoscopy, core needle biopsy
- Laboratory tests: Immunohistochemistry panels, biomarker assays
- Blood tests: MESOMARK (soluble mesothelin), osteopontin, fibulin-3
Reviewed by: Rod De Llano, J.D. — Texas Bar — 30+ years mesothelioma litigation
Last updated: March 15, 2026
Sources: American Cancer Society, National Cancer Institute, Cleveland Clinic
Our attorneys have handled mesothelioma cases for over 30 years. We can evaluate your situation, explain every option available to you, and answer your questions — all at no cost and with no obligation.
Request a Free Consultation
Your information is confidential and protected. We typically respond within 24 hours.
Call 1-800-400-1805 for immediate help.